Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription - PubMed (original) (raw)

Review

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

E J Arts et al. Antimicrob Agents Chemother. 1996 Mar.

No abstract available

PubMed Disclaimer

Similar articles

• A novel anticancer agent ARC antagonizes HIV-1 and HCV.
  Nekhai S, Bhat UG, Ammosova T, Radhakrishnan SK, Jerebtsova M, Niu X, Foster A, Layden TJ, Gartel AL. Nekhai S, et al. Oncogene. 2007 May 31;26(26):3899-903. doi: 10.1038/sj.onc.1210158. Epub 2006 Dec 18. Oncogene. 2007. PMID: 17173067
• Nucleoside spiroxiranes as suicide inhibitors of the human immunodeficiency virus.
  Bailey JM, Nelson KA. Bailey JM, et al. Biochem Soc Trans. 1995 Nov;23(4):619S. doi: 10.1042/bst023619s. Biochem Soc Trans. 1995. PMID: 8654804 No abstract available.
• L-Nucleosides as chemotherapeutic agents.
  Gumina G, Song GY, Chu CK. Gumina G, et al. FEMS Microbiol Lett. 2001 Aug 7;202(1):9-15. doi: 10.1111/j.1574-6968.2001.tb10773.x. FEMS Microbiol Lett. 2001. PMID: 11506901 Review.
• Inhibitors of HIV-1 transcription.
  Li CJ, Dezube BJ, Biswas DK, Ahlers CM, Pardee AB. Li CJ, et al. Trends Microbiol. 1994 May;2(5):164-9. doi: 10.1016/0966-842x(94)90666-1. Trends Microbiol. 1994. PMID: 8055180 Review.

Cited by

• In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
  Borroto-Esoda K, Myrick F, Feng J, Jeffrey J, Furman P. Borroto-Esoda K, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4387-94. doi: 10.1128/AAC.48.11.4387-4394.2004. Antimicrob Agents Chemother. 2004. PMID: 15504868 Free PMC article.
• Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.
  McSharry JJ, Lurain NS, Drusano GL, Landay AL, Notka M, O'Gorman MR, Weinberg A, Shapiro HM, Reichelderfer PS, Crumpacker CS. McSharry JJ, et al. Antimicrob Agents Chemother. 1998 Sep;42(9):2326-31. doi: 10.1128/AAC.42.9.2326. Antimicrob Agents Chemother. 1998. PMID: 9736557 Free PMC article.
• Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.
  Adkins JC, Peters DH, Faulds D. Adkins JC, et al. Drugs. 1997 Jun;53(6):1054-80. doi: 10.2165/00003495-199753060-00009. Drugs. 1997. PMID: 9179531 Review.
• Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses.
  Borbone N, Piccialli G, Roviello GN, Oliviero G. Borbone N, et al. Molecules. 2021 Feb 13;26(4):986. doi: 10.3390/molecules26040986. Molecules. 2021. PMID: 33668428 Free PMC article. Review.

References

1. 1. J Mol Biol. 1994 Oct 28;243(3):369-87 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320-4 - PubMed
3. 1. J Biol Chem. 1992 Feb 25;267(6):3589-96 - PubMed
4. 1. Mutat Res. 1988 Jul-Aug;200(1-2):133-47 - PubMed
5. 1. J Biol Chem. 1986 Dec 5;261(34):16037-42 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database